Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, and Monoclonal and Polyclonal Antibodies Research.
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab
NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial
Real-World Outcomes with Bispecific T-Cell Engagers (REALBiTE) for Relapsed or Refractory Large B-Cell Lymphoma: A Multi-Center, Retrospective Cohort Study
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study
Development and Use of Natural Language Processing for Identification of Distant Cancer Recurrence and Sites of Distant Recurrence Using Unstructured Electronic Health Record Data
Real-world outcomes of patients with metastatic breast cancer (BC) treated with osteoclast inhibitors (OIs).
Real-world efficacy of bone modifying agents (BMAs) in patients with breast cancer (BC) treated in an academic health system: Use of the “green button.
Impact of mortality reviews on supportive care utilization, end-of-life care, and inpatient mortality.